China SXT Pharmaceuticals Sells Shares for $100K
Ticker: SXTC · Form: 6-K · Filed: May 13, 2025 · CIK: 1723980
| Field | Detail |
|---|---|
| Company | China Sxt Pharmaceuticals, Inc. (SXTC) |
| Form Type | 6-K |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: capital-raise, share-issuance, definitive-agreement
TL;DR
SXT just sold 200k shares for $100k to an investor. Raising some cash.
AI Summary
On May 5, 2025, China SXT Pharmaceuticals, Inc. entered into a Securities Purchase Agreement with an investor to sell 200,000 Ordinary Shares. The Company expects to receive approximately $100,000 in gross proceeds from this offering, before deducting any applicable fees and expenses.
Why It Matters
This transaction provides China SXT Pharmaceuticals with additional capital, which could be used for operational needs or future growth initiatives.
Risk Assessment
Risk Level: medium — The company is raising capital through a share issuance, which can dilute existing shareholders and may indicate a need for funds.
Key Numbers
- $100,000 — Gross Proceeds (Expected amount raised from the sale of 200,000 Ordinary Shares.)
- 200,000 — Ordinary Shares (Number of shares sold in the offering.)
Key Players & Entities
- China SXT Pharmaceuticals, Inc. (company) — Filer and issuer of securities
- May 5, 2025 (date) — Date of Securities Purchase Agreement
- 200,000 Ordinary Shares (security) — Number of shares to be sold
- $100,000 (dollar_amount) — Aggregate gross proceeds from the offering
FAQ
What is the purpose of the Securities Purchase Agreement?
The agreement is for China SXT Pharmaceuticals, Inc. to sell and issue 200,000 Ordinary Shares to an investor.
When was the Securities Purchase Agreement entered into?
The agreement was entered into on May 5, 2025.
How many Ordinary Shares is China SXT Pharmaceuticals selling?
The company is selling 200,000 Ordinary Shares.
What are the expected gross proceeds from this offering?
The aggregate gross proceeds are expected to be approximately $100,000, before deducting fees and expenses.
Does the company file under Form 20-F or 40-F?
The company indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 13, 2025 regarding China SXT Pharmaceuticals, Inc. (SXTC).